GlassScriptPhysician profile
Vishal N Patel
NPI 1255548319
$285.45
in general payments reported to CMS, 2019-2025
10 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.73 · 2021: $26.02 · 2022: $29.34 · 2023: $31.65 · 2024: $33.20 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $81.75 | 2025 | |
| Stryker Corporation | $59.76 | 2025 | Actishield |
| Blue Earth Diagnostics | $26.02 | 2021 | |
| Neural Analytics, INC. | $23.73 | 2019 | |
| Coloplast Corp | $18.56 | 2023 | Porges Coloplast |
| Antares Pharma, INC. | $17.91 | 2022 | |
| Dendreon Pharmaceuticals LLC | $17.30 | 2024 | Provenge |
| Calyxo, INC. | $15.90 | 2024 | Cvac Aspiration System |
| Angiodynamics, INC. | $13.09 | 2023 | Nanoknife |
| Myriad Genetic Laboratories, INC. | $11.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.